Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Why is Shijiazhuang Yiling Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -5.17% and Operating profit at -180.22% over the last 5 years

With a growth in Net Sales of 8.65%, the company declared Very Positive results in Sep 25

The company has declared positive results in Jan 70 after 7 consecutive negative quarters
PRE-TAX PROFIT(Q) At CNY 365.98 MM has Grown at 338.45%
NET PROFIT(Q) At CNY 331.87 MM has Grown at 338.03%
RAW MATERIAL COST(Y) Fallen by -24.02% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 6.26%, its profits have fallen by -338.5%
At the current price, the company has a high dividend yield of 0

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shijiazhuang Yiling Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shijiazhuang Yiling Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

9.46%

-0.39

31.50%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-5.17%

EBIT Growth (5y)

-180.22%

EBIT to Interest (avg)

49.58

Debt to EBITDA (avg)

0.16

Net Debt to Equity (avg)

-0.10

Sales to Capital Employed (avg)

0.69

Tax Ratio

8.08%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

13.68%

ROE (avg)

11.15%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.43

EV to EBIT

-33.99

EV to EBITDA

-216.63

EV to Capital Employed

2.66

EV to Sales

4.27

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.82%

ROE (Latest)

-5.21%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 365.98 MM has Grown at 338.45%

NET PROFIT(Q)

At CNY 331.87 MM has Grown at 338.03%

RAW MATERIAL COST(Y)

Fallen by -24.02% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -17.82 %

NET SALES(Q)

At CNY 1,827.46 MM has Grown at 22.89%

-1What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.51 times

Here's what is working for Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 365.98 MM has Grown at 338.45%

over average net sales of the previous four periods of CNY -153.49 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 331.87 MM has Grown at 338.03%

over average net sales of the previous four periods of CNY -139.42 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 1,827.46 MM has Grown at 22.89%

over average net sales of the previous four periods of CNY 1,487.1 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Debt-Equity Ratio

Lowest at -17.82 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -24.02% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Inventory Turnover Ratio

Lowest at 1.51 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio